Get the Stockscreener App
5.12
3.76%
-0.20
Enveric Biosciences Inc stock is traded at $5.12, with a volume of 520.32K.
It is down -3.76% in the last 24 hours and up +172.34% over the past month.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
See More
Previous Close:
$5.32
Open:
$5.57
24h Volume:
520.32K
Relative Volume:
0.14
Market Cap:
$10.21M
Revenue:
-
Net Income/Loss:
$-8.77M
P/E Ratio:
-0.1863
EPS:
-27.4806
Net Cash Flow:
$-8.14M
1W Performance:
+42.22%
1M Performance:
+172.34%
6M Performance:
-23.58%
1Y Performance:
-68.63%
1-Day Range:
$4.99
$5.73
1-Week Range:
$3.555
$7.88
52-Week Range:
$1.71
$17.84
Enveric Biosciences Inc Stock (ENVB) Company Profile
Name
Enveric Biosciences Inc
Sector
Industry
Phone
(617) 444-8400
Address
245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE
Compare ENVB vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENVB
Enveric Biosciences Inc
|
5.1401 | 10.56M | 0 | -8.77M | -8.14M | -27.48 |
VRTX
Vertex Pharmaceuticals Inc
|
424.76 | 109.41B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
678.63 | 76.72B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
764.94 | 48.20B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.56 | 40.31B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
292.50 | 33.13B | 5.36B | 287.73M | 924.18M | 2.5229 |
Enveric Biosciences Inc Stock (ENVB) Latest News
What's going on with Enveric Biosciences stock on Friday? - MSN
Lakewood-Amedex appoints Enveric CEO to board of directors - Investing.com UK
Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors - Investing News Network
Enveric Biosciences surges over 90%, other psychedelic stocks soar in Monday pre-market: What's going on? - MSN
Lakewood-Amedex appoints Enveric CEO to board of directors By Investing.com - Investing.com Nigeria
Fresh off Nasdaq listing, Lakewood-Amedex taps biotech CEO for board - Stock Titan
ENVB stock is on track for its worst decline in over 10 weeks on discounted offering – but retail remains upbeat - MSN
MSN Money - MSN
Biotech Stocks To Keep An Eye OnApril 26th - MarketBeat
ENVB Jumps After New Patent Strengthens EB-003 Pipeline - timothysykes.com
ENVB Jumps As Enveric Wins Key U.S. Patent - StocksToTrade
ENVB Jumps As Enveric Wins New Patent For EB-003 - StocksToTrade
ENVB Surges As Enveric Wins Key U.S. Patent - timothysykes.com
Enveric Biosciences stock soars after Trump's psychedelics executive order - MSN
What's Going On With Enveric Biosciences Stock On Friday? - Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Biotech Stocks To Add to Your WatchlistApril 24th - MarketBeat
wow envb - Moomoo
Enveric Biosciences (NASDAQ: ENVB) registers resale of 6.82M shares - Stock Titan
Enveric BioSciences Surges Over 90%, Other Psychedelic Stocks Soar In Monday Pre-Market: What's Going On? - Dailyhunt
Enveric Biosciences to Participate in a Panel Discussion at Needham's Virtual Psychedelics Forum - Investing News Network
Enveric Biosciences Stock Soars After Trump's Psychedelics Executive Order - Sahm
Crude Oil Surges Over 6%; Investar Holding Shares Gain Following Q1 Earnings - Sahm
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Enveric Biosciences to Participate in a Panel Discussion at Needham’s Virtual Psychedelics Forum - Business Wire
Top Small Cap Stocks To Keep An Eye OnApril 20th - MarketBeat
Medical Stocks To ConsiderApril 20th - MarketBeat
Trending Stocks Today | Enveric Biosciences Surges 115.38% - Moomoo
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Enveric Biosciences (ENVB) Stock Surges Over 160% After Trump Executive Order on Psychedelics - MEXC Exchange
ENVB Stock Spikes As New U.S. Patent Fuels EB-003 Hype - StocksToTrade
ENVB soars 134% as market reacts to private placement closing and warrant-driven trading dynamics - Quiver Quantitative
Enveric Biosciences (ENVB) Stock Explodes 160%+ Following Trump's Psychedelic Executive Order - Blockonomi
US Stocks Mixed; Cleveland-Cliffs Shares Fall After Q1 Results - Benzinga
Enveric Biosciences Announces $13.9 Million Private Placement to Fund Neuroplastogenic Therapeutics Development - Minichart
ENVB Stock Spikes As New U.S. Patent Fuels Trading Momentum - timothysykes.com
Morning Market Movers: ENVB, PBM, PASG, ATAI See Big Swings - RTTNews
got lucky - Moomoo
Enveric Biosciences targets up to $13.9M in total proceeds via share and warrant offering - MSN
Enveric Biosciences Inc Stock (ENVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.17%
0.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):